Christopher D.M. Fletcher, M.D., M.B.,B.S.
This page shows the publications co-authored by Christopher Fletcher and Lynette Sholl.
In Response to "Reexamining the molecular findings in specialized stromal tumors of the prostate". Mod Pathol. 2021 Nov; 34(11):2082-2083.
Pseudoendocrine Sarcoma: Clinicopathologic Analysis of 23 Cases of a Distinctive Soft Tissue Neoplasm With Metastatic Potential, Recurrent CTNNB1 Mutations, and a Predilection for Truncal Locations. Am J Surg Pathol. 2021 Jun 03.
Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes. Mod Pathol. 2021 09; 34(9):1763-1779.
'Inflammatory myofibroblastic tumour'-like dedifferentiation of anaplastic lymphoma kinase-rearranged lung adenocarcinoma. Histopathology. 2016 Sep; 69(3):510-5.
Pathologic characteristics of NUT midline carcinoma arising in the mediastinum. Am J Surg Pathol. 2012 Aug; 36(8):1222-7.
Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod Pathol. 2019 06; 32(6):830-843.
Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas. Am J Surg Pathol. 2018 08; 42(8):1067-1075.
Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-?B regulatory genes. Mod Pathol. 2016 Jan; 29(1):67-74.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.